Abstract
Objective: We aimed to determine the incidence of growth failure in infants with necrotizing enterocolitis (NEC) or spontaneous intestinal perforation (SIP) and whether initial laparotomy versus peritoneal drainage (PD) impacted the likelihood of growth failure. Summary Background Data: Infants with surgical NEC and SIP have high mortality, and most have neurodevelopmental impairment and poor growth. Existing literature on growth outcomes for these infants is limited. Methods: This is a preplanned secondary study of the Necrotizing Enterocolitis Surgery Trial dataset. The primary outcome was growth failure (Z-score for weight <-2.0) at 18 to 22 months. We used logistic regression, including diagnosis and treatment, as covariates. Secondary outcomes were analyzed using the Fisher exact or Pearson χ2 test for categorical variables and the Wilcoxon rank sum test or one-way ANOVA for continuous variables. Results: Among 217 survivors, 207 infants (95%) had primary outcome data. Growth failure at 18 to 22 months occurred in 24/50 (48%) of NEC infants versus 65/157 (42%) SIP (P=0.4). The mean weight-for-age Z-score at 18 to 22 months in NEC infants was -2.05±0.99 versus -1.84±1.09 SIP (P=0.2), and the predicted mean weight-for-age Z-score SIP (Beta -0.27; 95% CI: -0.53, -0.01; P=0.041). Median declines in weight-for-age Z-score between birth and 18 to 22 months were significant in all infants but most severe (>2) in NEC infants (P=0.2). Conclusions: This first ever prospective study of growth outcomes in infants with surgical NEC or SIP demonstrates that growth failure is very common, especially in infants with NEC, and persists at 18-22 months.
| Original language | English |
|---|---|
| Pages (from-to) | 432-443 |
| Number of pages | 12 |
| Journal | Annals of Surgery |
| Volume | 280 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 1 2024 |
Bibliographical note
Publisher Copyright:Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Funding
This study was supported by the National Institutes of Health and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (U10 HD27871, U10 HD53119, UG1 HD21364, UG1 HD21373, UG1 HD21385, UG1 HD27851, UG1 HD27853, UG1 HD27856, UG1 HD27880, UG1 HD27904, UG1 HD34216, UG1 HD36790, UG1 HD40492, UG1 HD40689, UG1 HD53089, UG1 HD53109, UG1 HD68244, UG1 HD68270, UG1 HD68278, UG1 HD68263, UG1 HD68284, UG1 HD87226, UG1 HD87229) and the National Center for Advancing Translational Sciences (NCATS) (UL1 TR6, UL1 TR41, UL1 TR42, UL1 TR77, UL1 TR93, UL1 TR442, UL1 TR454, UL1 TR1117) provided grant support through cooperative agreements for the Neonatal Research Network’s Necrotizing Enterocolitis Surgery Trial (NEST). Additionally, the National Institutes of Health and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) provided grant support for Speer (1K08DK131326), and the National Institutes of Health and the National Heart, Lung, and Blood Institute (NHLBI) provided grant support for Ohls (1R01HL166254). This study was supported by the National Institutes of Health and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (U10 HD27871, U10 HD53119, UG1 HD21364, UG1 HD21373, UG1 HD21385, UG1 HD27851, UG1 HD27853, UG1 HD27856, UG1 HD27880, UG1 HD27904, UG1 HD34216, UG1 HD36790, UG1 HD40492, UG1 HD40689, UG1 HD53089, UG1 HD53109, UG1 HD68244, UG1 HD68270, UG1 HD68278, UG1 HD68263, UG1 HD68284, UG1 HD87226, UG1 HD87229) and the National Center for Advancing Translational Sciences (NCATS) (UL1 TR6, UL1 TR41, UL1 TR42, UL1 TR77, UL1 TR93, UL1 TR442, UL1 TR454, UL1 TR1117) provided grant support through cooperative agreements for the Neonatal Research Network's Necrotizing Enterocolitis Surgery Trial (NEST). Additionally, the National Institutes of Health and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) provided grant support for Speer (1K08DK131326), and the National Institutes of Health and the National Heart, Lung, and Blood Institute (NHLBI) provided grant support for Ohls (1R01HL166254).
| Funders | Funder number |
|---|---|
| Neonatal Research Network’s Necrotizing Enterocolitis Surgery Trial | |
| National Institutes of Health (NIH) | |
| European NEST | |
| Neonatal Research Network's Necrotizing Enterocolitis Surgery Trial | |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | UG1 HD27851, UG1 HD34216, UG1 HD68270, UG1 HD27853, UG1 HD68284, UG1 HD53109, UG1 HD27856, UG1 HD27904, UG1 HD53089, UG1 HD36790, UG1 HD40689, U10 HD53119, UG1 HD87229, U10 HD27871, UG1 HD68263, UG1 HD21385, UG1 HD68244, UG1 HD21364, UG1 HD68278, UG1 HD21373, UG1 HD40492, UG1 HD27880, UG1 HD87226 |
| National Center for Advancing Translational Sciences (NCATS) | UL1 TR442, UL1 TR454, UL1 TR1117 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1R01HL166254 |
| National Institute of Diabetes and Digestive and Kidney Diseases | 1K08DK131326 |
Keywords
- Growth failure
- infant
- laparotomy
- necrotizing enterocolitis
- peritoneal drain
- spontaneous intestinal perforation
ASJC Scopus subject areas
- Surgery
Fingerprint
Dive into the research topics of 'Surgical Necrotizing Enterocolitis and Spontaneous Intestinal Perforation Lead to Severe Growth Failure in Infants'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver